Frank Rimerman Advisors LLC Decreases Stock Holdings in Relx Plc (NYSE:RELX)

Frank Rimerman Advisors LLC trimmed its holdings in shares of Relx Plc (NYSE:RELX) by 35.2% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 6,636 shares of the technology company’s stock after selling 3,612 shares during the quarter. Frank Rimerman Advisors LLC’s holdings in Relx were worth $301,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently modified their holdings of the business. Private Trust Co. NA increased its position in Relx by 19.2% in the fourth quarter. Private Trust Co. NA now owns 1,237 shares of the technology company’s stock worth $56,000 after buying an additional 199 shares during the last quarter. Sage Mountain Advisors LLC grew its position in shares of Relx by 5.1% in the fourth quarter. Sage Mountain Advisors LLC now owns 5,292 shares of the technology company’s stock valued at $240,000 after purchasing an additional 258 shares in the last quarter. Peapack Gladstone Financial Corp grew its position in shares of Relx by 5.7% in the third quarter. Peapack Gladstone Financial Corp now owns 4,924 shares of the technology company’s stock valued at $234,000 after purchasing an additional 267 shares in the last quarter. EWA LLC grew its position in shares of Relx by 5.2% in the third quarter. EWA LLC now owns 5,501 shares of the technology company’s stock valued at $253,000 after purchasing an additional 272 shares in the last quarter. Finally, Marks Group Wealth Management Inc grew its position in shares of Relx by 1.3% in the fourth quarter. Marks Group Wealth Management Inc now owns 26,196 shares of the technology company’s stock valued at $1,190,000 after purchasing an additional 325 shares in the last quarter. 15.02% of the stock is owned by hedge funds and other institutional investors.

Relx Price Performance

NYSE:RELX opened at $49.63 on Tuesday. The firm has a market capitalization of $92.23 billion, a price-to-earnings ratio of 26.68, a P/E/G ratio of 2.73 and a beta of 0.90. Relx Plc has a 52-week low of $40.25 and a 52-week high of $51.99. The stock has a fifty day moving average of $48.94 and a 200 day moving average of $47.62. The company has a debt-to-equity ratio of 1.46, a quick ratio of 0.47 and a current ratio of 0.52.

Relx Increases Dividend

The firm also recently disclosed a semi-annual dividend, which will be paid on Wednesday, June 25th. Investors of record on Friday, May 9th will be paid a dividend of $0.5586 per share. This is a positive change from Relx’s previous semi-annual dividend of $0.23. The ex-dividend date is Friday, May 9th. This represents a yield of 1.6%. Relx’s dividend payout ratio (DPR) is currently 59.68%.

Wall Street Analysts Forecast Growth

Several equities analysts have recently weighed in on the company. Redburn Atlantic assumed coverage on Relx in a research report on Wednesday, January 8th. They issued a “buy” rating for the company. Barclays raised Relx from an “equal weight” rating to an “overweight” rating in a research note on Friday. Finally, StockNews.com lowered Relx from a “buy” rating to a “hold” rating in a research note on Tuesday, March 4th.

Relx Company Profile

RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.